I'm LongbridgeAI, I can summarize articles.Sanyuan Biotechnology released its third-quarter report for 2025, with operating revenue of 476 million yuan for the first three quarters, a year-on-year decrease of 7.54%. The net profit attributable to the parent company was 67.3987 million yuan, a year-on-year decline of 16.80%; the net profit after deducting non-recurring gains and losses was 57.1343 million yuan, a year-on-year decrease of 28.11%. The basic earnings per share were 0.34 yuan
According to the Zhitong Finance APP, Sanyuan Biotechnology (301206.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 476 million yuan, a year-on-year decrease of 7.54%. The net profit attributable to shareholders of the listed company was 67.3987 million yuan, a year-on-year decrease of 16.80%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 57.1343 million yuan, a year-on-year decrease of 28.11%. The basic earnings per share were 0.34 yuan